The global glucose injection market is expected to grow at a CAGR of 4.5% during the forecast period, from 2021 to 2030. The growth of this market can be attributed to the increasing number of diabetic patients and rising awareness about diabetes among people. The increasing prevalence of diabetes is also driving the growth of this market. The global glucose injection market is segmented on the basis of type, application, and region. On the basis of type, it is segmented into 5% dextrose injection, 10% dextrose injection, 50% dextrose injection and 70% dextrose injection. On the basis of application it is segmented into sports medicine, first aid treatment and trophotherapy (a form or therapy that uses natural substances such as herbs or vitamins). On the basis on region it includes North America (US, Canada), Latin America (Mexico), Europe (Germany), Asia Pacific (China) and Middle East & Africa (Saudi Arabia).
Some Of The Growth Factors Of This Market:
- The global population is increasing, which will lead to an increase in the number of people with diabetes.
- The cost of insulin has increased, which will lead to a decrease in the number of people with diabetes who can afford it and an increase in the number of people who are uninsured or underinsured.
- There is a lack of awareness about how to manage diabetes, which leads to an increase in complications from uncontrolled blood sugar levels and an increased risk for developing type 2 diabetes.
- There is a lack of access to healthcare providers that specialize in managing type 1 and type 2 diabetes, which leads to more complications from uncontrolled blood sugar levels and more cases of type 2 diabetes developing over time as well as higher rates for mortality among those with either form of the disease due to complications from uncontrolled blood sugar levels or other health conditions that develop because they have not been diagnosed or treated properly for their condition(s).
- There are new treatments being developed for both types 1 and 2 diabetes that may help reduce some side effects associated with these diseases such as weight gain, high cholesterol levels, high triglyceride levels, low HDL cholesterol level (good cholesterol), nerve damage (neuropathy), kidney damage (nephropathy), eye problems (retinopathy) etc, but there are also risks associated with these treatments such as hypoglycemia (low blood sugar) if taken incorrectly or if someone has another medical condition that makes them more susceptible than others would be; weight gain; liver problems; heart problems; bone loss etc, so it's important for patients considering any treatment option related to their condition(s) including insulin injections/pumps/glucagon kits/insulin pens etc, talk about all possible risks and benefits before making any decisions about what treatment options they want pursued first - this includes talking about what treatment options they want pursued first even if they're not sure yet because there's no harm done by discussing all possible options at this point since nothing can be done until after diagnosis anyway - so it's better safe than sorry when it comes down to making decisions related to one's health!.
Industry Growth Insights published a new data on “Glucose Injection Market”. The research report is titled “Glucose Injection Market research by Types (5% Dextrose Injection, 10% Dextrose Injection, 50% Dextrose Injection, 70% Dextrose Injection, Other), By Applications (Sports, First-Aid Treatment, Trophotherapy, Other), By Players/Companies Pfizer, Amphastar, ChanGee, HAIXIN”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Glucose Injection Market Research Report
By Type
5% Dextrose Injection, 10% Dextrose Injection, 50% Dextrose Injection, 70% Dextrose Injection, Other
By Application
Sports, First-Aid Treatment, Trophotherapy, Other
By Companies
Pfizer, Amphastar, ChanGee, HAIXIN
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
239
Number of Tables & Figures
168
Customization Available
Yes, the report can be customized as per your need.
Global Glucose Injection Market Report Segments:
The global Glucose Injection market is segmented on the basis of:
Types
5% Dextrose Injection, 10% Dextrose Injection, 50% Dextrose Injection, 70% Dextrose Injection, Other
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Sports, First-Aid Treatment, Trophotherapy, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Pfizer
- Amphastar
- ChanGee
- HAIXIN
Highlights of The Glucose Injection Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- 5% Dextrose Injection
- 10% Dextrose Injection
- 50% Dextrose Injection
- 70% Dextrose Injection
- Other
- By Application:
- Sports
- First-Aid Treatment
- Trophotherapy
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Glucose Injection Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Glucose injection is a medical procedure that uses a needle to inject glucose into the bloodstream. Glucose is a type of sugar that the body uses for energy.
Some of the key players operating in the glucose injection market are Pfizer, Amphastar, ChanGee, HAIXIN.
The glucose injection market is expected to register a CAGR of 4.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Glucose Injection Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Glucose Injection Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Glucose Injection Market - Supply Chain
4.5. Global Glucose Injection Market Forecast
4.5.1. Glucose Injection Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Glucose Injection Market Size (000 Units) and Y-o-Y Growth
4.5.3. Glucose Injection Market Absolute $ Opportunity
5. Global Glucose Injection Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Glucose Injection Market Size and Volume Forecast by Type
5.3.1. 5% Dextrose Injection
5.3.2. 10% Dextrose Injection
5.3.3. 50% Dextrose Injection
5.3.4. 70% Dextrose Injection
5.3.5. Other
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Glucose Injection Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Glucose Injection Market Size and Volume Forecast by Application
6.3.1. Sports
6.3.2. First-Aid Treatment
6.3.3. Trophotherapy
6.3.4. Other
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Glucose Injection Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Glucose Injection Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Glucose Injection Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Glucose Injection Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Glucose Injection Demand Share Forecast, 2019-2026
9. North America Glucose Injection Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Glucose Injection Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Glucose Injection Market Size and Volume Forecast by Application
9.4.1. Sports
9.4.2. First-Aid Treatment
9.4.3. Trophotherapy
9.4.4. Other
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Glucose Injection Market Size and Volume Forecast by Type
9.7.1. 5% Dextrose Injection
9.7.2. 10% Dextrose Injection
9.7.3. 50% Dextrose Injection
9.7.4. 70% Dextrose Injection
9.7.5. Other
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Glucose Injection Demand Share Forecast, 2019-2026
10. Latin America Glucose Injection Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Glucose Injection Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Glucose Injection Market Size and Volume Forecast by Application
10.4.1. Sports
10.4.2. First-Aid Treatment
10.4.3. Trophotherapy
10.4.4. Other
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Glucose Injection Market Size and Volume Forecast by Type
10.7.1. 5% Dextrose Injection
10.7.2. 10% Dextrose Injection
10.7.3. 50% Dextrose Injection
10.7.4. 70% Dextrose Injection
10.7.5. Other
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Glucose Injection Demand Share Forecast, 2019-2026
11. Europe Glucose Injection Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Glucose Injection Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Glucose Injection Market Size and Volume Forecast by Application
11.4.1. Sports
11.4.2. First-Aid Treatment
11.4.3. Trophotherapy
11.4.4. Other
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Glucose Injection Market Size and Volume Forecast by Type
11.7.1. 5% Dextrose Injection
11.7.2. 10% Dextrose Injection
11.7.3. 50% Dextrose Injection
11.7.4. 70% Dextrose Injection
11.7.5. Other
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Glucose Injection Demand Share, 2019-2026
12. Asia Pacific Glucose Injection Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Glucose Injection Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Glucose Injection Market Size and Volume Forecast by Application
12.4.1. Sports
12.4.2. First-Aid Treatment
12.4.3. Trophotherapy
12.4.4. Other
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Glucose Injection Market Size and Volume Forecast by Type
12.7.1. 5% Dextrose Injection
12.7.2. 10% Dextrose Injection
12.7.3. 50% Dextrose Injection
12.7.4. 70% Dextrose Injection
12.7.5. Other
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Glucose Injection Demand Share, 2019-2026
13. Middle East & Africa Glucose Injection Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Glucose Injection Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Glucose Injection Market Size and Volume Forecast by Application
13.4.1. Sports
13.4.2. First-Aid Treatment
13.4.3. Trophotherapy
13.4.4. Other
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Glucose Injection Market Size and Volume Forecast by Type
13.7.1. 5% Dextrose Injection
13.7.2. 10% Dextrose Injection
13.7.3. 50% Dextrose Injection
13.7.4. 70% Dextrose Injection
13.7.5. Other
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Glucose Injection Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Glucose Injection Market: Market Share Analysis
14.2. Glucose Injection Distributors and Customers
14.3. Glucose Injection Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Pfizer
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Amphastar
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. ChanGee
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. HAIXIN
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. COMPANY5
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. COMPANY6
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. COMPANY7
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. COMPANY8
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. COMPANY9
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook